The Clinical and Molecular Phenotyping (CMP) Group at IRBLleida is a young and growing translational research team based in Lleida, Spain, working in close collaboration with the Hospital Universitari Arnau de Vilanova.We are internationally recognised for our work on circulating non-coding RNA biomarkers — microRNAs, lncRNAs and tRNA-derived fragments — across infectious and chronic diseases. A distinctive focus of the group is the study of pathogen-derived small RNAs as innovative markers of infection-related complications and host–pathogen interactions.Our work follows an integrated translational pipeline — from clinical need and cohort-based discovery through assay development, validation and implementation readiness — supported by transcriptomic, proteomic and machine learning platforms.
What we offer:
A co-developed MSCA-PF 2026 proposal within a dynamic, growing and internationally connected group.
Ideal candidate:
▸ Expertise in biomarker development (from discovery to validation)
▸ Strong statistical analysis skills
▸ Experience with non-coding RNAs is a significant plus
▸ Motivated to develop an independent research line in a collaborative environment
[email protected] — Subject: MSCA-PF 2026 Application
Job Type: Full-time
Work Location: In person
